NEW YORK (
) hit a new 52-week low Wednesday as it is currently trading at $3.39, below its previous 52-week low of $3.40 with 67,420 shares traded as of 10:02 a.m. ET. Average volume has been 955,800 shares over the past 30 days.
MannKind has a market cap of $457.4 million and is part of the
industry. Shares are down 57.3% year to date as of the close of trading on Tuesday.
MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer.
- Practice your MNKD trading strategies and win cash in our stock game.
TheStreet Ratings rates MannKind as a
. Among the areas we feel are negative, one of the most important has been a generally disappointing historical performance in the stock itself. You can view the full
or get investment ideas from our